pretickt

When does Quest Diagnostics report earnings?

Quest Diagnostics Incorporated · end-of-day data as of Nov 13, 2026

Quest Diagnostics
DGX · $28.56B
$259.600.0%
Nov 13, 2026 · close
$240$260SepOctNov9:3016:003 months +10.3%Nov 13 · close
▲ 7
  • ConsensusBuy · 17
  • P/E vs sector-19.7%
  • FCF yield+4.8%
  • MAs4 of 4
  • MA20×50Golden 9d ago
  • MACD0.82
  • Sector▲ +15.9%
Neutral
  • Earnings in88d
  • P/E25.9x
  • RSI69
  • Support-5.5%
  • Off 52w high-0.9%
  • Volume0.7x
  • Bollingerupper half
  • News0.00
  • Trendsideways
  • 52w range$171–$262
  • ATR+2.3%
  • Off ATH-0.9%
▼ 3
  • PT$249.63 -3.8%
  • P/E vs own+18.6%
  • Insiders-$15.63M

Updates with the 15-min delayed price. Not a forecast or investment advice.

Quest Diagnostics DGX reports its next earnings on Tuesday, Feb 9, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $2.68 on revenue of $3.04B. Quest Diagnostics beat the EPS estimate in 6 of its last 8 reports, and the stock moved ±5.6% on average the session after. The last report, on Oct 22, 2026: EPS of $3.00 against $2.87 expected and revenue of $3.1B against $3.05B; the stock rose 1.8% the next session.

The stock around its reports

⇔⇕$153$186$219$252Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26AADEADEDEADEDEDEDEDEDE

Last close $259.60 · +67.9% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +10.0% year over year, free cash flow 18.5% of revenue, operating margin 15.5%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$3.1B2.78$574M33.6%15.5%10.1%
Q2 FY2026Jun 30, 2026$3.04B2.84$330M33.7%15.1%10.5%
Q1 FY2026Mar 31, 2026$2.9B2.24$164M32.5%13.8%8.7%
Q4 FY2025Dec 31, 2025$2.81B2.18$307M32.6%13.9%8.7%
Q3 FY2025Sep 30, 2025$2.82B2.16$419M33.7%13.7%8.7%
Q2 FY2025Jun 30, 2025$2.76B2.47$436M34.2%15.9%10.2%
Q1 FY2025Mar 31, 2025$2.65B1.94$197M32.5%13.0%8.3%
Q4 FY2024Dec 31, 2024$2.62B1.95$341M32.7%13.8%8.5%